Stonepine Capital Management’s AYTU BioPharma AYTU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.77M | Buy |
812,676
+348,955
| +75% | +$761K | 1.74% | 16 |
|
|
2025
Q1 | $795K | Buy |
463,721
+56,172
| +14% | +$96.3K | 0.77% | 27 |
|
|
2024
Q4 | $693K | Sell |
407,549
-93,409
| -19% | -$159K | 0.56% | 35 |
|
|
2024
Q3 | $1.18M | Buy |
500,958
+28,489
| +6% | +$66.9K | 0.74% | 25 |
|
|
2024
Q2 | $1.38M | Hold |
472,469
| – | – | 1.26% | 15 |
|
|
2024
Q1 | $1.44M | Hold |
472,469
| – | – | 1.14% | 14 |
|
|
2023
Q4 | $1.34M | Buy |
472,469
+100
| +0% | +$284 | 0.58% | 14 |
|
|
2023
Q3 | $1.28M | Hold |
472,369
| – | – | 0.42% | 23 |
|
|
2023
Q2 | $756K | Buy |
+472,369
| New | +$756K | 0.27% | 21 |
|
|
2021
Q2 | – | Sell |
-18,146
| Closed | -$2.76M | – | 28 |
|
|
2021
Q1 | $2.76M | Sell |
18,146
-51,793
| -74% | -$7.87M | 1.49% | 18 |
|
|
2020
Q4 | $8.37M | Buy |
+69,939
| New | +$8.37M | 6.4% | 4 |
|